Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 fludarabine 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Bone Marrow Transplantation 2 pirtobrutinib 1 obinutuzumab 1 ibrutinib 1 acalabrutinib 1 Whole-Body Irradiation 1 Tacrolimus 1 Stem Cell Transplantation 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Leukapheresis 1 Filgrastim 1 Busulfan 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡